Intellegens selected as AI company of the year
Intellegens has won the ‘AI Company of the Year’ award at the Cambridge Independent Science and Technology Awards, selected by an expert panel from a strong shortlist of technology businesses following a record number of entries.
7th China (Shenzhen) Innovation & Entrepreneurship International Competition
The 7th China (Shenzhen) Innovation & Entrepreneurship International Competition (“IEIC”) is the largest international innovation and entrepreneurship competition in Shenzhen, China and attracts startups and innovation talents from all over the world. Cambridge Hacklab Academy Ltd as co-organizer in IEIC UK division sincerely invite start-ups and entrepreneurs to join in the event this year!
Men's Health Week and Corazon's Charity of the Year
Today is the start of Men's Health Week and a joint effort is required to change attitudes to men's mental health.
Metrion Biosciences appoints Dr Steve Jenkinson as VP, Drug Discovery and Safety Assessment to strengthen US operations
Appointment supports growth of Metrion’s pre-clinical ion channel contract research and safety pharmacology services.
Human capabilities vs skills: the answer to hard to fill vacancies?
Are hard-to-fill job vacancies keeping you up at night? If you’re struggling to find the right candidates for the right roles, you might be asking yourself where you’re going wrong. But the talent is out there – all we need is a fresh approach to finding them.
World-first NHS test to curb transfusion side-effects for thousands with Inherited Blood Disorders
The NHS is set to introduce a new genetic blood-matching test – developed through a collaboration with partners including the NIHR BioResource - for thousands living with sickle-cell disease or thalassaemia that could reduce some of the side-effects of transfusion treatments.
Study involving BioResource volunteers finds that obesity accelerates loss of COVID-19 vaccination immunity
Following publication of a new study led by scientists at the Universities of Cambridge and Edinburgh, we asked co-lead of the Cambridge team, Dr James Thaventhiran, about the role of the BioResource and our volunteers in facilitating this study that suggests people with obesity are likely to need more frequent COVID-19 booster doses to maintain immunity.
Choosing to study child nursing at ARU is best decision I ever made
Sean Haskell-Mills, 31, 2nd Year student studying Child Nursing at ARU Cambridge from Cornwall shares her account of studying child nursing at ARU.
H.E.L Group expands range of BioXplorer bioreactors to support bioprocess development
Automated parallel bioreactor offering updated with increased capabilities for multi-parameter process development BioXplorer systems are modular and highly configurable with automation, process control, safety monitoring, and data recording enabled through control
Cambridge Healthcare Research Appoints the Head of their Competitive Intelligence Division, Solici
Cambridge Healthcare Research announces the promotion of Senior Principal Brendan Walkden to Head of Solici
The importance of getting a workplace investigation right
The importance of conducting a workplace investigation correctly and fairly is paramount, with this only being achieved with the correct polices and procedures being implemented and followed.
Axol Bioscience collaborates with StrataStem to deliver stem cell based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification.
ELRIG UK Announces Prof Janet Hemingway and Dr Dave Powell as Keynote Speakers at Drug Discovery 2023
ELRIG Drug Discovery 2023 at ACC Liverpool (18–19 October) to focus on diverse thinking and new perspectives
CN Bio appoints Dr. Samantha Macro as Chief Financial Officer
Key executive appointment provides extensive financial industry experience as the Company implements ambitious global growth strategy
New horizons for Guardtech Group as international presence continues to grow
Cleanroom construction specialists establishing their brands overseas with string of exciting European projects
Avacta Achieves Second Milestone in AffyXell Joint Venture Triggering Increased Equity Stake
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to announce that a second milestone equity payment has been triggered resulting in an increase in Avacta’s shareholding in AffyXell Therapeutics ("AffyXell"),
Navigating biotech's changing landscape
BioBeat23 provided a platform for investors, entrepreneurs, and industry experts to delve into the evolving world of biotechnology. Against the backdrop of economic adversity, this gathering of minds shed light on the key mindsets and strategies required for success in the biotech industry. Organised by Miranda Weston-Smith, Founder of BioBeat, and Alisa Molotova, Investment Manager at Martlet…
‘UK science powerhouse’ opens its doors
Across the city, leading science companies and innovation parks will open their doors to showcase the cluster’s contribution to STEM innovation in the UK and strengthen its diverse, equitable and inclusive community.
Epicentre, Haverhill to run “coping with menopausal symptoms” sessions
The EpiCentre at Haverhill is to run a series of 90-minute sessions to help women who struggle with menopausal symptoms.
Pangaea Data awarded strategic partnership by Mersey Care NHS Foundation Trust and the University of Liverpool’s Mental Health Research for Innovation Centre (M-RIC)
Pangaea Data awarded strategic partnership by Mersey Care NHS Foundation Trust and the University of Liverpool’s Mental Health Research for Innovation Centre (M-RIC) to characterize patients across hard-to-diagnose mental health conditions.
Avacta acquires Coris Bioconcept, adding a broad range of marketed professional-use rapid tests to the Group
Acquisition consistent with Avacta Diagnostics M&A strategy and complements earlier acquisition of Launch Diagnostics.
France: A step towards more regulated drug prices
2022 was an expensive year for public spending in France, that led to a €18.9 billion debt for the social security system[1]
Cresset releases Flare™ V7
Flare™ is a comprehensive drug design platform that integrates the power of ligand and
